How Do Lipoprotein(a) Concentrations Affect Clinical Outcomes for Patients With Stable Coronary Artery Disease Who Underwent Different Dual Antiplatelet Therapy After Percutaneous Coronary Intervention?

How Do Lipoprotein(a) Concentrations Affect Clinical Outcomes for Patients With Stable Coronary Artery Disease Who Underwent Different Dual Antiplatelet Therapy After Percutaneous Coronary Intervention?

Background Lp(a) (lipoprotein[a]) plays an important role in predicting cardiovascular events in patients with coronary artery disease through its proatherogenic and prothrombotic effects. We hypothesized that prolonged dual antiplatelet therapy (DAPT) might be beneficial for patients undergoing per...

Full description

Bibliographic Details
Main Authors: Kongyong Cui, Dong Yin, Chenggang Zhu, Weihua Song, Hongjian Wang, Lei Jia, Rui Zhang, Haoyu Wang, Zhongxing Cai, Lei Feng, Kefei Dou
Format: Article
Language:English
Published: Wiley 2022-05-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
clinical outcome
coronary artery disease
drug‐eluting stent
dual antiplatelet therapy
lipoprotein(a)
percutaneous coronary intervention
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.121.023578

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.121.023578

Similar Items